Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Impulsive Behavior

• Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
• Impulsivity Domains and Subjective Response
• Dialectical Behavioral Therapy Skills for Impulsive Aggression
• Oral Naltrexone In Pediatric Eating Disorders
• Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder
• Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia
• Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
• Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
• Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
• A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
• A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
• Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
• Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
• Impulsivity and Stimulant Administration
• Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
• Open-Label, Extension Study to 810P202
• A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Nicotine Treatment of Impulsivity in Parkinson's Disease
• A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors
• Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)
• A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
• Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression
• Serotonin, Impulsivity, and Cocaine Dependence Treatment
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.